StonvexLoading…
StonvexStonvexStonvexCore line items from NMAX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $51.66M | $189.25M | $137.01M | $91.74M |
Operating Income | $-4.47M | $-99.85M | $-95.18M | $-87.98M |
Net Income | $-2.19M | $-99.50M | $-96.52M | $-75.18M |
EPS (Diluted) | $-0.02 | $-0.96 | $-1.00 | $-1.12 |
Total Assets | $226.26M | $239.84M | $233.33M | $259.80M |
Total Liabilities | $119.23M | $133.79M | $127.37M | $152.94M |
Cash & Equivalents | $17.20M | $20.43M | $14.18M | $33.84M |
Free Cash Flow OCF − CapEx | $-2.89M | $-107.11M | $-108.87M | $-39.64M |
Shares Outstanding | 128.49M | 108.21M | 100.94M | 86.94M |